Scienture Holdings Inc. | Micro-cap | Healthcare
$1.07
-4.46%
| Scienture Holdings Stock Comparison:
Scienture Holdings vs Walgreens BootsScienture Holdings vs High TideScienture Holdings vs PetMed ExpressScienture Holdings vs Wellgistics HealthScienture Holdings vs Hong Kong PharmaScienture Holdings vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 10.3K
Gross Profit 673 6.56%
Operating Income -3.6M -34,814.94%
Net Income -3.1M -29,869.34%
EPS (Diluted) $-0.33

Balance Sheet Metrics

Total Assets 106.4M
Total Liabilities 25.2M
Shareholders Equity 81.2M
Debt to Equity 0.31

Cash Flow Metrics

Operating Cash Flow -1.4M
Free Cash Flow -3.0M

Revenue & Profitability Trend

Scienture Holdings Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i136.6K8.3M10.3M9.9M17.1M
Cost of Goods Sold i130.6K5.7M4.7M5.1M11.4M
Gross Profit i6.0K2.6M5.5M4.7M5.7M
Gross Margin % i4.4%31.4%53.8%48.0%33.3%
Operating Expenses
Research & Development i2.2M1.4M993.2K899.7K-
Selling, General & Administrative i12.1M8.5M6.6M7.5M7.5M
Other Operating Expenses i416.3K1.4M993.2K899.7K-
Total Operating Expenses i14.7M11.2M8.6M9.3M7.5M
Operating Income i-14.7M-7.3M-2.0M-3.7M-1.8M
Operating Margin % i-10,758.7%-87.8%-19.9%-37.3%-10.4%
Non-Operating Items
Interest Income i135.3K4.2K21.0K0-
Interest Expense i1.3M1.2M336.2K23.6K29.4K
Other Non-Operating Income-2.9M-5.3M-47.5K-1.6M-726.0K
Pre-tax Income i-18.8M-13.7M-2.4M-5.3M-2.5M
Income Tax i-534.4K----
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i9.1M-17.8M-3.9M-5.3M-2.5M
Net Margin % i6,634.7%-215.7%-38.1%-53.8%-14.8%
Key Metrics
EBITDA i-14.5M-6.2M-1.8M-3.6M-1.7M
EPS (Basic) i$2.69$-23.35$-6.15$-9.75$-4.95
EPS (Diluted) i$2.48$-23.35$-6.15$-9.75$-4.95
Basic Shares Outstanding i3375325764058564863542449513708
Diluted Shares Outstanding i3375325764058564863542449513708

Income Statement Trend

Scienture Holdings Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i308.1K151.9K1.1M3.1M5.9M
Short-term Investments i-----
Accounts Receivable i11.1K821.8K629.9K979.0K805.0K
Inventory i096865.5K56.3K1.3M
Other Current Assets-----
Total Current Assets i6.3M2.8M2.1M4.4M9.2M
Non-Current Assets
Property, Plant & Equipment i218.9K806.6K1.1M1.3M549.8K
Goodwill i119.1M9.0M000
Intangible Assets i76.4M9.0M---
Long-term Investments-----
Other Non-Current Assets534.4K-450.8K-0
Total Non-Current Assets i98.5M9.8M1.6M1.4M571.4K
Total Assets i104.9M12.5M3.7M5.8M9.8M
Liabilities
Current Liabilities
Accounts Payable i2.9M2.1M528.0K477.0K256.8K
Short-term Debt i2.8M6.7M363.5K178.6K356.2K
Current Portion of Long-term Debt-----
Other Current Liabilities930.7K2.0M916.5K--
Total Current Liabilities i7.9M11.6M2.1M926.0K842.2K
Non-Current Liabilities
Long-term Debt i768.7K434.2K1.2M1.1M271.3K
Deferred Tax Liabilities i13.5M----
Other Non-Current Liabilities1.3M----
Total Non-Current Liabilities i17.9M434.2K1.2M1.1M271.3K
Total Liabilities i25.8M12.0M3.4M2.0M1.1M
Equity
Common Stock i87968281
Retained Earnings i-39.0M-33.2M-19.7M-16.2M-10.9M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i79.1M542.4K342.9K3.8M8.7M
Key Metrics
Total Debt i3.5M7.1M1.6M1.2M627.5K
Working Capital i-1.6M-8.8M-53.7K3.4M8.4M

Balance Sheet Composition

Scienture Holdings Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-18.8M-13.7M-2.4M-5.3M-2.5M
Depreciation & Amortization i53.4K1.0M194.7K138.9K102.5K
Stock-Based Compensation i-257.8K254.1K181.2K1.4M
Working Capital Changes i-2.6M5.2M134.2K1.2M-2.6M
Operating Cash Flow i-15.8M-6.9M-1.6M-3.6M-2.3M
Investing Activities
Capital Expenditures i-0749-22.6K-37.5K
Acquisitions i133.0K-344.5K0-0
Investment Purchases i-2.5M----
Investment Sales i-----
Investing Cash Flow i-2.4M-344.5K749-22.6K-37.5K
Financing Activities
Share Repurchases i-----
Dividends Paid i-14.9M----
Debt Issuance i3.1M400.0K0--
Debt Repayment i0-150.0K0-225.0K0
Financing Cash Flow i-13.0M1.9M239.0K-450.0K5.3M
Free Cash Flow i-14.3M-2.1M-1.6M-2.6M-2.3M
Net Change in Cash i-31.2M-5.4M-1.3M-4.1M2.9M

Cash Flow Trend

Scienture Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 2.37
Price to Book 0.25
Price to Sales 152.25
PEG Ratio -0.04

Profitability Ratios

Profit Margin 4.39%
Operating Margin -12,824.74%
Return on Equity -54.26%
Return on Assets -19.67%

Financial Health

Current Ratio 0.11
Debt to Equity 5.30

Per Share Data

EPS (TTM) $0.51
Book Value per Share $4.83
Revenue per Share $0.02

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
scnx19.5M2.370.25-54.26%4.39%5.30
Walgreens Boots 10.5B27.101.46-69.58%-4.07%409.88
High Tide 248.5M-61.201.77-6.69%-1.76%44.69
PetMed Express 62.6M303.000.650.36%0.15%1.15
Wellgistics Health 56.8M-5.4710.27-2,124.65%-135.22%571.67
Hong Kong Pharma 11.5M6.262.31-0.59%-0.13%47.60

Financial data is updated regularly. All figures are in the company's reporting currency.